Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Liver Transplantation for Hepatocellular Carcinoma: Management After the Transplant.

Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY; This manuscript is a work-product of the American Society of Transplantation Liver Intestine Community of Practice.

Am J Transplant. 2019 Nov 11. doi: 10.1111/ajt.15697. [Epub ahead of print]

PMID:
31710773
2.

A Cautionary Report of Doxycycline-induced Autoimmune Hepatitis.

Fakhreddine A, Frenette C.

Hepatology. 2019 Nov 7. doi: 10.1002/hep.31029. [Epub ahead of print]

PMID:
31698502
3.

Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education.

Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, Abdallah SJ, Jensen D, Lebouché B, Brouillette MJ, Klein M, Szabo J, Frenette C, Giannakis A, Jenabian MA.

Cannabis Cannabinoid Res. 2019 Sep 23;4(3):204-213. doi: 10.1089/can.2018.0068. eCollection 2019.

PMID:
31579835
4.

Acute Liver Failure from Exertional Heatstroke Can Result in Excellent Long-term Survival with Liver Transplantation.

Bi X, Deising A, Frenette C.

Hepatology. 2019 Sep 11. doi: 10.1002/hep.30938. [Epub ahead of print]

PMID:
31509612
5.

Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys.

Mitchell R, Taylor G, Rudnick W, Alexandre S, Bush K, Forrester L, Frenette C, Granfield B, Gravel-Tropper D, Happe J, John M, Lavallee C, McGeer A, Mertz D, Pelude L, Science M, Simor A, Smith S, Suh KN, Vayalumkal J, Wong A, Amaratunga K; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2019 Sep 9;191(36):E981-E988. doi: 10.1503/cmaj.190361.

6.

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk.

Frenette CT, Isaacson AJ, Bargellini I, Saab S, Singal AG.

Mayo Clin Proc Innov Qual Outcomes. 2019 Jul 11;3(3):302-310. doi: 10.1016/j.mayocpiqo.2019.04.005. eCollection 2019 Sep.

7.

Time-Series Analysis of Health Care-Associated Infections in a New Hospital With All Private Rooms.

McDonald EG, Dendukuri N, Frenette C, Lee TC.

JAMA Intern Med. 2019 Aug 19. doi: 10.1001/jamainternmed.2019.2798. [Epub ahead of print]

8.

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.

Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC.

Gastroenterology. 2019 Nov;157(5):1253-1263.e2. doi: 10.1053/j.gastro.2019.07.040. Epub 2019 Jul 30.

PMID:
31374215
9.

Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.

Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette CT, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG.

Clin Gastroenterol Hepatol. 2019 Jul 26. pii: S1542-3565(19)30786-4. doi: 10.1016/j.cgh.2019.07.042. [Epub ahead of print]

PMID:
31357028
10.

Epidemiology of Clostridioides difficile infection in Canada: A six-year review to support vaccine decision-making.

Xia Y, Tunis MC, Frenette C, Katz K, Amaratunga K, Rose SR, House A, Quach C.

Can Commun Dis Rep. 2019 Jul 4;45(7-8):191-211. doi: 10.14745/ccdr.v45i78a04. eCollection 2019 Jul 4.

11.

Antimicrobial utilization data: Does point prevalence data correlate with defined daily doses?

Lee SB, Thirion DJG, Irfan N, Sung M, Brooks A, Al-Mutawa F, Frenette C, Mertz D.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):920-921. doi: 10.1017/ice.2019.154. Epub 2019 Jun 11.

PMID:
31182182
12.

Joint Modeling of Resistance to Six Antimicrobials in Urinary Escherichia coli Isolates in Quebec, Canada.

Soucy JR, Schmidt AM, Frenette C, Dolcé P, Boudreault AA, Buckeridge DL, Quach C.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e02531-18. doi: 10.1128/AAC.02531-18. Print 2019 Jul.

13.

A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology.

Fakhreddine AY, Frenette CT, Konijeti GG.

Gastroenterol Res Pract. 2019 Mar 7;2019:6156581. doi: 10.1155/2019/6156581. eCollection 2019. Review.

14.

Changes in vascular accesses and in incidence rates of dialysis-related bloodstream infections in Québec, Canada, 2011-2017.

Fortin É, Ouakki M, Tremblay C, Villeneuve J, Desmeules S, Parisien N, Moisan D, Frenette C; for SPIN-BAC-HD.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):627-631. doi: 10.1017/ice.2019.65. Epub 2019 Apr 8.

PMID:
30957725
15.

Healthcare-associated bloodstream infection trends under a provincial surveillance program.

Fakih I, Fortin É, Smith MA, Carignan A, Tremblay C, Villeneuve J, Moisan D, Frenette C, Quach C, Schmidt AM; for SPIN-BACTOT.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):307-313. doi: 10.1017/ice.2018.357.

PMID:
30887941
16.

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

Pate J, Gutierrez JA, Frenette CT, Goel A, Kumar S, Manch RA, Mena EA, Pockros PJ, Satapathy SK, Yimam KK, Gish RG.

BMJ Open Gastroenterol. 2019 Feb 1;6(1):e000256. doi: 10.1136/bmjgast-2018-000256. eCollection 2019.

17.

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND.

Gastroenterology. 2019 May;156(6):1683-1692.e1. doi: 10.1053/j.gastro.2019.01.027. Epub 2019 Jan 18.

PMID:
30660729
18.

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.

Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, Szabo J, Haraoui LP, de Pokomandy A, Tsoukas C, Falutz J, LeBlanc R, Giannakis A, Frenette C, Jenabian MA, Bourbeau J, Klein MB.

HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8.

19.

Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States.

Frenette CT.

Hepatol Commun. 2019 Jan 1;3(1):5-7. doi: 10.1002/hep4.1299. eCollection 2019 Jan.

20.

Trapped vessel of abdominal pain with hepatomegaly: A case report.

Grandhe S, Lee JA, Chandra A, Marsh C, Frenette CT.

World J Hepatol. 2018 Nov 27;10(11):887-891. doi: 10.4254/wjh.v10.i11.887.

21.

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct-Acting Antivirals for Hepatitis C.

Pan JJ, Bao F, Du E, Skillin C, Frenette CT, Waalen J, Alaparthi L, Goodman ZD, Pockros PJ.

Hepatol Commun. 2018 Sep 21;2(11):1320-1330. doi: 10.1002/hep4.1228. eCollection 2018 Nov.

22.

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.

Mehta G, Rousell S, Burgess G, Morris M, Wright G, McPherson S, Frenette C, Cave M, Hagerty DT, Spada A, Jalan R.

J Clin Exp Hepatol. 2018 Sep;8(3):224-234. doi: 10.1016/j.jceh.2017.11.006. Epub 2017 Nov 22.

23.

A ten-year review of healthcare-associated bloodstream infections from forty hospitals in Québec, Canada.

Fakih I, Fortin É, Smith MA, Carignan A, Tremblay C, Villeneuve J, Moisan D, Frenette C, Quach C; for SPIN-BACTOT.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1202-1209. doi: 10.1017/ice.2018.185. Epub 2018 Aug 29.

PMID:
30156168
24.

Hepatocellular cancer pain: impact and management challenges.

Christian-Miller N, Frenette C.

J Hepatocell Carcinoma. 2018 Jul 19;5:75-80. doi: 10.2147/JHC.S145450. eCollection 2018. Review.

25.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

26.

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.

Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Cheng JT, Cave M, Khaderi SA, Massoud O, Pyrsopoulos N, Park JS, Robinson JM, Yamashita M, Spada AP, Chan JL, Hagerty DT.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):774-783.e4. doi: 10.1016/j.cgh.2018.06.012. Epub 2018 Jun 18.

27.

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report.

Costiniuk CT, Karamchandani J, Bessissow A, Routy JP, Szabo J, Frenette C.

BMC Infect Dis. 2018 May 8;18(1):210. doi: 10.1186/s12879-018-3128-3.

28.

Health Care-Associated Infections after Subarachnoid Hemorrhage.

Abulhasan YB, Alabdulraheem N, Schiller I, Rachel SP, Dendukuri N, Angle MR, Frenette C.

World Neurosurg. 2018 Jul;115:e393-e403. doi: 10.1016/j.wneu.2018.04.061. Epub 2018 Apr 18.

PMID:
29678711
29.

Healthcare-associated infections in the neurological intensive care unit: Results of a 6-year surveillance study at a major tertiary care center.

Abulhasan YB, Rachel SP, Châtillon-Angle MO, Alabdulraheem N, Schiller I, Dendukuri N, Angle MR, Frenette C.

Am J Infect Control. 2018 Jun;46(6):656-662. doi: 10.1016/j.ajic.2017.12.001. Epub 2018 Feb 1.

PMID:
29395511
30.

Hypoalbuminemia is Associated With Significantly Higher Liver Transplant Waitlist Mortality and Lower Probability of Receiving Liver Transplant.

Ahn J, Sundaram V, Ayoub WS, Frenette C, Wong RJ.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):913-917. doi: 10.1097/MCG.0000000000000984.

PMID:
29356783
31.

Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.

Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):955-964. doi: 10.1016/j.cgh.2017.11.037. Epub 2017 Nov 23.

32.

Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Semret M, Schiller I, Jardin BA, Frenette C, Loo VG, Papenburg J, McNeil SA, Dendukuri N.

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

33.

A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation.

Nhu QM, Du EZ, Kiyani A, Frenette CT.

BMJ Case Rep. 2017 Nov 4;2017. pii: bcr-2017-221028. doi: 10.1136/bcr-2017-221028.

35.

Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y; Quebec Clostridium difficile Infection Surveillance Program (QCISP).

Am J Infect Control. 2017 Sep 1;45(9):964-968. doi: 10.1016/j.ajic.2017.04.002. Epub 2017 May 23.

PMID:
28549882
36.

Epidemiology and outcome of antimicrobial resistance to gram-negative pathogens in bacteriuric kidney transplant recipients.

Delmas-Frenette C, Dorais M, Tavares-Brum A, Frenette C, Yang B, Medani S, Duclos A, Rouleau D, Mawad H, Barama A, Cardinal H.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12722. Epub 2017 Jul 3.

PMID:
28486744
37.

The Role of Regorafenib in Hepatocellular Carcinoma.

Frenette CT.

Gastroenterol Hepatol (N Y). 2017 Feb;13(2):122-124. No abstract available.

38.

The role of regorafenib in hepatocellular carcinoma.

Frenette CT.

Clin Adv Hematol Oncol. 2017 Feb;15(2):121-123. Review. No abstract available.

PMID:
28398282
39.

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).

Abou-Alfa GK, Yen CJ, Hsu CH, O'Donoghue J, Beylergil V, Ruan S, Pandit-Taskar N, Gansukh B, Lyashchenko SK, Ma J, Wan P, Shao YY, Lin ZZ, Frenette C, O'Neil B, Schwartz L, Smith-Jones PM, Ohtomo T, Tanaka T, Morikawa H, Maki Y, Ohishi N, Chen YC, Agajanov T, Boisserie F, Di Laurenzio L, Lee R, Larson SM, Cheng AL, Carrasquilo JA.

Cancer Chemother Pharmacol. 2017 Feb;79(2):421-429. doi: 10.1007/s00280-017-3241-9. Epub 2017 Jan 24.

40.

Novel second-line treatments for hepatocellular carcinoma: Discussion.

Frenette CT, Lencioni R, Finn RS.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):12-13. No abstract available.

PMID:
27930619
41.

Second-line therapy for patients with hepatocellular carcinoma.

Frenette CT.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):3-5. No abstract available.

PMID:
27930616
42.

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Nhu QM, Knowles H, Pockros PJ, Frenette CT.

World J Respirol. 2016;6(3):69-75. Epub 2016 Nov 28.

43.

Evaluating the impact of the multiplex respiratory virus panel polymerase chain reaction test on the clinical management of suspected respiratory viral infections in adult patients in a hospital setting.

Yee C, Suarthana E, Dendukuri N, Nicolau I, Semret M, Frenette C.

Am J Infect Control. 2016 Nov 1;44(11):1396-1398. doi: 10.1016/j.ajic.2016.04.221. Epub 2016 Jun 13.

PMID:
27311514
44.

Impact of an Infection Control and Antimicrobial Stewardship Program on Solid Organ Transplantation and Hepatobiliary Surgical Site Infections.

Frenette C, Sperlea D, Leharova Y, Thirion DJ.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1468-1474. Epub 2016 Oct 3.

PMID:
27692005
45.

Surveillance for Hepatocellular Carcinoma.

Frenette C.

Gastroenterol Hepatol (N Y). 2016 Jun;12(6):394-6. No abstract available.

46.

Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.

Yan M, Ha J, Aguilar M, Liu B, Frenette CT, Bhuket T, Wong RJ.

J Clin Gastroenterol. 2017 Apr;51(4):378-383. doi: 10.1097/MCG.0000000000000590.

PMID:
27380460
47.

Surveillance for hepatocellular carcinoma.

Frenette C.

Clin Adv Hematol Oncol. 2016 Jun;14(6):407-9. No abstract available.

PMID:
27379808
48.

End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ.

Hepatol Int. 2016 Sep;10(5):838-46. doi: 10.1007/s12072-016-9735-4. Epub 2016 May 24.

PMID:
27221700
49.

Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections.

Frenette C, Sperlea D, Tesolin J, Patterson C, Thirion DJ.

Am J Infect Control. 2016 Sep 1;44(9):977-82. doi: 10.1016/j.ajic.2016.02.029. Epub 2016 Apr 25.

PMID:
27125912
50.

An Unexpected Pulmonary Complication Following Transcatheter Arterial Chemoembolization of a Small Hepatocellular Carcinoma.

Nhu QM, Knowles H, Pockros PJ, Frenette CT.

J Clin Gastroenterol. 2016 Jul;50(6):524-5. doi: 10.1097/MCG.0000000000000524. No abstract available.

Supplemental Content

Loading ...
Support Center